Cédric Rébé
Inserm · 155 works · 10,066 citations · h-index 49
Top works
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
- Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
- Specific involvement of caspases in the differentiation of monocytes into macrophages
- Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer Cells
- The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
- Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
- T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
- Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells
- STAT3 activation
- Caspase-8 prevents sustained activation of NF-κB in monocytes undergoing macrophagic differentiation
- Interleukin-1β and Cancer
- FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
- Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis
- Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells
- MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells